Ulrika Yngve
Researcher at Department of Medicinal Chemistry; Preparative Medicinal Chemistry
- Telephone:
- +46 18 471 41 24
- E-mail:
- ulrika.yngve@scilifelab.uu.se
- Visiting address:
- Uppsala Biomedicinska Centrum, BMC, Husarg. 3
- Postal address:
- Box 574
751 23 UPPSALA
- CV:
- Download CV
Short presentation
Head of Facility, Medicinal Chemistry, Lead Identification, Drug Discovery and Development Platform, Science for Life Laboratory. Information about the platform can be found at https://www.scilifelab.se/platforms/ddd.

Publications
Selection of publications
-
Part of Journal of Medicinal Chemistry, p. 3915-3934, 2020
- DOI for Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
- Download full text (pdf) of Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
-
Part of Nature Communications, 2018
- DOI for A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
- Download full text (pdf) of A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
-
Part of Neuropharmacology, p. 293-300, 2017
-
Part of MedChemComm, p. 422-431, 2013
-
Part of Chemistry and Biodiversity, p. 2442-2452, 2012
Recent publications
-
Toward generalizable predictive models for DNA-encoded libraries
Part of Drug Discovery Today, 2026
- DOI for Toward generalizable predictive models for DNA-encoded libraries
- Download full text (pdf) of Toward generalizable predictive models for DNA-encoded libraries
-
Part of Journal of Medicinal Chemistry, p. 3915-3934, 2020
- DOI for Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
- Download full text (pdf) of Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
-
Part of Nature Communications, 2018
- DOI for A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
- Download full text (pdf) of A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
-
Automated GMP-production of α-[11 C]methyl-L-tryptophan using a tracer production system (TPS)
Part of Journal of labelled compounds & radiopharmaceuticals, p. 1106-1109, 2018
-
Part of Neuropharmacology, p. 293-300, 2017
All publications
Articles in journal
-
Toward generalizable predictive models for DNA-encoded libraries
Part of Drug Discovery Today, 2026
- DOI for Toward generalizable predictive models for DNA-encoded libraries
- Download full text (pdf) of Toward generalizable predictive models for DNA-encoded libraries
-
Part of Journal of Medicinal Chemistry, p. 3915-3934, 2020
- DOI for Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
- Download full text (pdf) of Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
-
Part of Nature Communications, 2018
- DOI for A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
- Download full text (pdf) of A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
-
Automated GMP-production of α-[11 C]methyl-L-tryptophan using a tracer production system (TPS)
Part of Journal of labelled compounds & radiopharmaceuticals, p. 1106-1109, 2018
-
Part of Neuropharmacology, p. 293-300, 2017
-
Tracing BACE: Synthesis and evaluation of beta-secretase inhibitors as ligands for PET imaging
Part of Journal of labelled compounds & radiopharmaceuticals, 2015
-
Part of MedChemComm, p. 422-431, 2013
-
Part of Chemistry and Biodiversity, p. 2442-2452, 2012
-
Part of Journal of Medicinal Chemistry, p. 6866-6880, 2012
-
Part of Nuclear Medicine and Biology, p. 1073-1078, 2004
-
Microwave accelerated 68Ga-labelling of oligonucleotides
Part of Journal of Labelled Compounds & Radiopharmaceuticals, p. 79-89, 2004
-
Labelling of octreotide using Br-76-prosthetic groups
Part of Journal of labelled compounds & radiopharmaceuticals, p. 561-573, 2001
-
Part of European Journal of Pharmaceutical Sciences, p. 179-186, 2000
-
Part of Nuclear Medicine and Biology, p. 851-853, 2000
-
Part of Acta Chemica Scandinavica, p. 508-512, 1999
-
Part of Acta Chemica Scandinavica, p. 651-669, 1999
Conference papers
-
Tritium labeling of a class of spirooxazaindolamines possessing analgesic properties.
Part of Synth. Appl. Isot. Labelled Compd., Proc. Int. Symp., 8th, p. 285-288, 2004
-
Part of Synth. Appl. Isot. Labelled Compd. 1997, Proc. Int. Symp., 6th, p. 303-305, 1998
Patents
-
2014
-
2014
-
2014
-
2011
-
Preparation of imidazolyl-pyrimidine derivatives as GSK3 inhibitors.
2008
-
Preparation of arylimidazopyridine derivatives for use as GSK3 modulators.
2008
-
Preparation of imidazopyridinecarboxamide derivatives for use as GSK3 modulators.
2008
-
Preparation of piperazinyl quinazolines as 5-HT6 modulators.
2007
-
Preparation of piperazinyl quinazolines as 5-HT6 modulators.
2007
-
2006
-
Preparation of five-membered heterocyclic compounds as mGluR5 receptor antagonists.
2004